GLOW LIFETECH CORP. (9DO) - Total Liabilities
Based on the latest financial reports, GLOW LIFETECH CORP. (9DO) has total liabilities worth €1.48 Million EUR (≈ $1.73 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GLOW LIFETECH CORP. operating cash flow efficiency to assess how effectively this company generates cash.
GLOW LIFETECH CORP. - Total Liabilities Trend (2021–2024)
This chart illustrates how GLOW LIFETECH CORP.'s total liabilities have evolved over time, based on quarterly financial data. Check how resilient are GLOW LIFETECH CORP.'s assets to evaluate the company's liquid asset resilience ratio.
GLOW LIFETECH CORP. Competitors by Total Liabilities
The table below lists competitors of GLOW LIFETECH CORP. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Algorhythm Holdings, Inc.
NASDAQ:RIME
|
USA | $10.74 Million |
|
Thunderstruck Resources Ltd
V:AWE
|
Canada | CA$747.18K |
|
Nippon Active Value Fund Plc
LSE:NAVF
|
UK | GBX4.13 Million |
|
Can Fite Biopharma Ltd
TA:CANF
|
Israel | ILA3.92 Million |
|
Sunshine Biopharma Inc
NASDAQ:SBFM
|
USA | $7.29 Million |
|
FATHOM NICKEL INC.
F:6Q5
|
Germany | €163.50K |
|
Cheer Holding Inc.
NASDAQ:CHR
|
USA | $40.56 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down GLOW LIFETECH CORP.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GLOW LIFETECH CORP. (9DO) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GLOW LIFETECH CORP.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GLOW LIFETECH CORP. (2021–2024)
The table below shows the annual total liabilities of GLOW LIFETECH CORP. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.15 Million ≈ $1.35 Million |
-51.70% |
| 2023-12-31 | €2.38 Million ≈ $2.78 Million |
+104.10% |
| 2022-12-31 | €1.17 Million ≈ $1.36 Million |
+255.79% |
| 2021-12-31 | €328.03K ≈ $383.50K |
-- |
About GLOW LIFETECH CORP.
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products, as well as precision-dosed capsules. It has exclusive North American rights for the production,… Read more